BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yu LP, Li YJ, Wang T, Tao YX, Zhang M, Gu W, Yu J, Yang XX. In vivo recognition of bioactive substances of Polygonum multiflorum for protecting mitochondria against metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2023; 29(1): 171-189 [PMID: 36683716 DOI: 10.3748/wjg.v29.i1.171]
URL: https://www.wjgnet.com/1007-9327/full/v29/i1/171.htm
Number Citing Articles
1
Sisi Chen, Qilong Li, Hanjing Shi, Fengna Li, Yehui Duan, Qiuping Guo. New insights into the role of mitochondrial dynamics in oxidative stress-induced diseasesBiomedicine & Pharmacotherapy 2024; 178: 117084 doi: 10.1016/j.biopha.2024.117084
2
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
3
Hye Ji Choi, Hyo Lim Lee, In Young Kim, Ho Jin Heo. Polygonum multiflorum Inhibits Pulmonary Inflammation and Fibrosis in PM2.5-Induced Dysfunction Through the Regulation of the TLR4/TGF-β1 Signaling Pathway in MiceInternational Journal of Molecular Sciences 2025; 26(11): 5080 doi: 10.3390/ijms26115080
4
Jingxia Du, Tingting Wang, Chengyao Xiao, Yibo Dong, Shiyao Zhou, Yujiao Zhu. Pharmacological Activation of AMPK Prevents Drp1-mediated Mitochondrial Fission and Alleviates Hepatic Steatosis In vitroCurrent Molecular Medicine 2024; 24(12): 1506 doi: 10.2174/0115665240275594231229121030
5
Zhihui Li, Yanqiu Gu, Jianbo Yang, Shaozhan Wang, Shengnan Li, Panpan Chen, Ru Yao, Fangbin Liu, Ying Wang, Rong Wang, Yongfang Yuan. Emodin and physcion alleviate cholestatic liver injury by targeting FXR: hepatoprotective components identified in processed Polygonum multiflorum Thunb. using a comprehensive two-dimensional biochromatography systemFrontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1706401
6
Kangjie li, Jie Wang, Ming Dang, Runxin Ren, Maomao Fu, Jing Wang, Qiao Zhang, Chongbo Zhao. Global research trends in Chinese medicine for the treatment of non-alcoholic fatty liver disease (NAFLD): A bibliometric studyPharmacological Research - Modern Chinese Medicine 2025; 14: 100585 doi: 10.1016/j.prmcm.2025.100585